Home > Press > Distinguished William and Mary Professor Joins Luna Innovations
Dr. Brian Holloway Named Director of Contract Research for nanoWorks Division in Danville
Distinguished William and Mary Professor Joins Luna Innovations
Danville, VA | Posted on August 16, 2006
Brian Holloway, Ph.D., has recently joined Luna’s nanoWorks division as Director of Contract Research. Dr. Holloway is formerly a tenured associate professor in the Department of Applied Science at The College of William and Mary, where his research group patented carbon nanosheets, a new two-dimensional nanostructure of carbon that has potential uses in sensors, fuel cells, batteries and medical devices. His group authored more than 10 papers on the nanosheets, including one that appeared in The Journal of Chemical Physics (issue May 21, 2006), a publication of the American Institute of Physics.
Throughout his career, Dr. Holloway has been actively involved in developing faster and cheaper ways to produce carbon nanotubes. In collaboration with the NASA’s Langley Research Center, his team used Jefferson Lab's (the U.S. Department of Energy’s national laboratory for nuclear physics research) Free-Electron Laser to explore the fundamental science of how and why nanotubes form.
With three patents related to nanotechnology, Dr. Holloway specializes in the synthesis of new materials and characterization of thin films, surfaces and interfaces. He has been a principal investigator on more than $8.2 million of externally funded research projects. In 2006, Dr. Holloway was named the William and Mary Art and Sciences Distinguished Associate Professor.
He earned a master’s degree and doctorate in Mechanical Engineering from Stanford University, and received a bachelor’s degree from the University of Florida.
Dr. Holloway compliments the senior management team at Luna’s nanoWorks Division, which includes:
Robert P. Lenk, Ph.D., President – Dr. Lenk is the founder of three companies, has been involved with two initial public offerings, and is experienced in bringing new pharmaceuticals to market. He has served as President of Oncovector Inc., a biopharmaceutical company and is also a former President and Chief Executive Officer of Therapeutics 2000, an inhalation pharmaceutical research company. Dr. Lenk holds a doctorate in Cell Biology from the Massachusetts Institute of Technology.
Stephen R. Wilson, Ph.D., Chief Scientific Officer – Dr. Wilson is a pioneer in fullerene chemistry and a founder and former Chief Scientific Officer of one of the first pharmaceutical companies specializing in creating therapeutics from fullerene technology. He is also a founder and former Director of the Center for Advanced Materials and Nanotechnology at New York University. Dr Wilson holds 16 patents and received his bachelor’s, master’s and doctoral degrees from Rice University.
Kenneth L. Walker, Ph.D., Executive Vice President – Dr. Walker is a founder and former President of Specialty Photonic Devices, a business unit of OFS Fitel which focused on the development of proprietary materials and which was purchased from Lucent Technologies, Inc. He is also a former head of optical fiber research at Bell Laboratories. Dr. Walker received a bachelor’s degree from the California Institute of Technology and a doctorate from Stanford University. He is a member of the National Academy of Engineers and holds more than 50 patents.
About Luna nanoWorks:
Luna nanoWorks is a division of Luna Innovations Incorporated. Luna nanoWorks is developing products empowered by nanomaterials, with an initial application focused on medical imaging. The company also manufactures high-quality carbon nanomaterials, including single-walled carbon nanotubes (SWCNT) and proprietary TRIMETASPHERE™ carbon nanomaterials.
For more information, please click here.
Director of Marketing & Communications
Copyright © Luna nanoWorks
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Thinnest feasible membrane produced April 17th, 2014
INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014
Engineers develop new materials for hydrogen storage April 15th, 2014
Industrial Nanotech, Inc. Lands First Major Order from Pemex, Mexico’s State-Owned Oil and Gas Company April 14th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
'Exotic' material is like a switch when super thin April 18th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Nanoparticles cause cancer cells to self-destruct April 3rd, 2014
A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014
Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014